Longevity clinics are opening up across the globe. More people are eager to test a range of biomarkers to assess their pace of aging. And, research suggests we play a major role in not only how long we live but how long we live in good health.
“We’re in the middle of a healthspan revolution,” says Peter Diamandis, longevity expert, entrepreneur, and executive founder of Singularity University. “You don’t want to be the last person to miss it.” Diamandis recently launched a new XPRIZE valued at $101 million with over 200 signups to find novel therapeutics to reverse aging by a decade.
